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ABSTRACT 16 
In this work, we provide proof-of-concept of formation, physical characteristics and 17 
potential use as a drug delivery formulation of Pickering (PE) emulsions obtained by a 18 
novel method that combines nanoprecipitation with subsequent spontaneous 19 
emulsification process. To this end, pre-formed ultra-small (d.~10 nm) nanoprecipitated 20 
nanoparticles of hydrophobic derivatives of cashew tree gum grafted with polylactide 21 
(CGPLAP), were conceived to stabilize Pickering emulsions obtained by spontaneous 22 
emulsification. These were also loaded with Amphotericin B (AmB), a drug of low oral 23 
bioavailability used in the therapy of neglected diseases such as leishmaniasis. The graft 24 
reaction was performed in two CG/PLA molar ratio conditions (1:1 and 1:10). Emulsions 25 
were prepared by adding the organic phase (Miglyol 812®) in the aqueous phase 26 
(nanoprecipitated CGPLAP), resulting the immediate emulsion formation.  The isolation 27 
by centrifugation does not destabilize or separate the nanoparticles from oil droplets of 28 
the PE emulsion.  . Emulsions with CGPLAP 1:1 presented unimodal distributions at 29 
different CGPLA concentration, lower values in size and PDI and the best stability over 30 
time. The AmB was incorporated in the emulsions with a process  efficiency of 20 to 47 31 
%, as determined by UV-VIS. AmB in CGPLAP emulsions is in less aggregated state 32 
than observed in commercial AmB formulation. 33 
Keywords: Pickering emulsion; cashew gum;  poly-L-lactide; copolymer; 34 
nanoparticles; amphotericin B.  35 
 36 
 37 
INTRODUCTION 38 
 39 
The first studies documenting the ability of solid particles to stabilize oil droplets 40 
in water were reported by Ramsden and Pickering and date back from more than a century 41 
ago [1]. Pickering emulsions, either o/w, w/o or multiple, are singled out from classical 42 
ones, as they are stabilized by solid particles and by the absence of surfactants [2]. By 43 
avoiding the need of use of synthetic surfactants, Pickering emulsions offer several 44 
advantages over their classical counterparts, such as better stability, low toxicity and less 45 
pollution to the environment. Over recent years, Pickering emulsions stabilized using 46 
different type of particles have been reported. In a study, halloysite nanotubes 47 
(HNT)((Al2Si2O5(OH)4·nH2O)) molecularly imprinted, that have been developed to 48 
extract herbicides from water [3] . The same research group, has recently published other 49 
studies based on Pickering emulsion by interfacial molecular imprinting  and Pickering 50 
emulsion polymerization to recognize bovine hemoglobin using different strategies, 51 
namely HNT and magnetic nanoparticles [4], hydroxyapatite hybridized polydopamine 52 
polymers [5]; [6] . Another study found evidence of the feasibility to obtain Pickering 53 
emulsions responsive to pH changes. These particles are based on polysiloxane 54 
microsphere bearing phenolphthalein groups, turned from pink to deep red with the 55 
augment of pH from 9 to 12. The emulsions also exhibited doubly pH-responsive 56 
property: two emulsification/demulsification processes occurred at pH 9 and pH 12, 57 
respectively [7]. 58 
Despite the great interest focused on Pickering emulsions stabilized by inorganic and 59 
synthetic polymeric particles, only recently  researchers have started to account for the 60 
use of natural edible polysaccharides, proteins and other natural food constituents for this 61 
purpose. Therefore, particulate systems comprising alginate [8], modified starch [9, 10], 62 
chitin nanocrystals [11], chitosan [12], cellulose nanocrystals [13-15]; soy protein 63 
nanoparticles [16] or whey protein microgels [17] have been reported. 64 
Cashew gum (CG) is an heteropolysaccharide comprised by ȕ-D-galactose (72-65 
73%), D-D-glucose (11-14%), L-arabinose (4,6%), L-ramnose (3-4%), D-glucuronic acid 66 
(4-7%) and a small fraction (5-8 %) of protein [18]. The solubility and biodegradability 67 
in physiological conditions of CG, anticipates its amenability and potential use to develop 68 
matrices to associate and release low molar mass drugs, biologics and cells [18]. In this 69 
paper, we report for the first time, the use of self-assembled nanoparticles of CG grafted 70 
with polylactic acid (PLA) obtained by nanoprecipitation, and subsequently its use to 71 
obtain stable Pickering emulsions by spontaneous emulsification. Synthesis of CG - poly-72 
L-lactide derivatives were previous described by Reicher [19]. These type of hybrid 73 
materials offer improved functional properties in the development of drug delivery 74 
formulations [20] including their enhanced biodegradability [21]. We have selected 75 
amphotericin B (AmB) (Scheme 1) as the drug to load into the Pickering emulsions. AmB 76 
is a potent fungistatic and fungicide drug produced by the actinomycetes Streptomycetes 77 
nodosus [22] that was approved for clinical use by FDA in 1959 [23]. AmB is also 78 
prescribed in the treatment of visceral leishmaniasis.  It is a lipophilic drug that binds to 79 
lipids and intercalates into lipid bilayers that then associate to form transmembrane pores 80 
[24]. Its selectivity for fungi is associated with its greater affinity for ergosterol than to 81 
cholesterol.  However, non-selective toxicity towards human erythrocytes is mediated by 82 
its state of aggregation [25]. AmB was introduced in the market as a micellar suspension 83 
with sodium deoxychlolate (Fungizon®) for intravenous administration. Later, other 84 
formulations were introduced, including: a liposomal formulation (Ambisome ®), 85 
whereby AmB is present in a high state of aggregation, as well as in the lipid complex, 86 
Abelcet®; a colloidal dispersion, Amphocil®; and in an emulsion product in association 87 
with Intralipid®. These and other type of lipid-based formulations have been known to 88 
reduce the systemic toxicity without compromising the therapeutic efficacy of AmB [26- 89 
27]. It has been proposed that emulsion-based formulations that preserve and favor the 90 
release of the monomeric form of AmB below the critical concentration for self-91 
association are less toxic than micellar suspensions [28]. Recently, it has also been shown 92 
that a heating treatment of AmB (20 min at 70 Û&FRPELQHGZLWKWKHIRUPXODWLRQRID93 
microemulsion leads to a new state of aggregation of AmB that exhibits lower toxicity 94 
and increases the in vitro and in vivo efficacy [29]. AmB also shows very low oral 95 
bioavailability due to its structural features that violate /LSLQVN\¶VUXOHe.g., low Log P, 96 
high Mw, large polar surface area).  Hence, novel pharmaceutical formulations of AmB 97 
are of great interest with a view to contribute to increase its pharmacological 98 
bioavailability for oral and other routes of administration, while exerting control on its 99 
drug release.  100 
 101 
Scheme 1 102 
 103 
EXPERIMENTAL SECTION 104 
 105 
Materials 106 
Cashew (Anacardium occidentale) gum exudate (CG) was kindly donated by EMBRAPA 107 
(Empresa Brasileira de Pesquisa Agropecuária, City, Brazil). It was isolated and purified 108 
according with the protocol previously developed by our Group [30]. CG was grafted 109 
with poly-L-lactide in two different CG:PLA molar ratio (1:1 and 1:10) as detailed by 110 
Reicher [19]. All chemical reagents were from Sigma-Aldrich (São Paulo, Brazil) and 111 
used without further purification. Amphotericin B was supplied by Ethycal (Fortaleza, 112 
Brazil). Dimethyl sulfoxide (DMSO) and acetone were from Synth (São Paulo, Brazil) 113 
and Miglyol 812® (coconut triglycerides of caprylic and capric fatty acids) was from 114 
Cremer Oleo (Witten, Germany).  115 
 116 
 117 
 118 
Synthesis of Pickering Emulsions 119 
The Pickering emulsions were prepared using the general principle of spontaneous 120 
emulsification, which is the fundamental principle for the preparation protocol of 121 
chitosan-based nanocapsules that have been extensively used in previous studies [31-32], 122 
though with modifications.  Briefly, CGPLAP of the two different CG/PLA molar ratios 123 
(1:1 and 1:10) were initially fully dissolved in DMSO at 10 mg/mL. An aliquot of this 124 
solution poured into distilled water to a final volume of 20 mL and final three 125 
concentrations (0.5, 1.0 and 2.0 mg/mL). This led to the formation of nanoprecipitated 126 
particles of CGPLAP, thus comprising the aqueous phase. The organic phase consisted 127 
of 0.5 mL of ethanol, 125 µL of Miglyol and 9.5 mL of acetone. The organic phase (~10 128 
mL) was immediately poured into the aqueous phase containing the CGPLAP self-129 
assembled nanoparticles under quiescent conditions and the solution immediately turned 130 
milky. The solvents were subsequently evaporated in a rotavapor at 45°C. The thus 131 
obtained Pickering emulsion was isolated by centrifugation for 1 h at 25°C and at 15000 132 
x G. The resulting milky cream on the solution was removed with a micropipette and 133 
stored under refrigeration until subsequent use. The emulsion type was determined by the 134 
drop test [33]. Briefly, a drop of emulsion was added to either water or Miglyol and the 135 
ability of the sample to disperse was observed. 136 
 137 
Characterization of physical properties 138 
 139 
The particle size distributions of the CGPLAP nanoparticles and Pickering emulsions 140 
obtained from them were characterized by dynamic light scattering with non-invasive 141 
back scattering (DLS-NIBS) at 25°C upon irradiation of the sample with a 4 mW 142 
helium/neon red laser (O=633 nm) and detection was at an angle of 173°. The zeta 143 
potential of the Pickering emulsions was measured by mixed laser Doppler velocimetry 144 
and phase analysis light scattering (M3±PALS). A Nanosizer ZS 3600 (Malvern 145 
Instruments Ltd., Worcestershire, UK) was used for both determinations. The samples 146 
were diluted 1:50 in water for size measurements and for zeta potential measurements.  147 
 148 
 149 
Storage Stability 150 
 151 
The storage stability of Pickering emulsions was determined in isolated formulations by 152 
measuring the particle size and polydispersity index using DLS-NIBS as described above. 153 
To this end, the emulsions were kept in refrigeration (~4 °C) and measurements were 154 
registered weekly [34]. 155 
 156 
Drug encapsulation 157 
 158 
To encapsulate amphotericin B (AmB) into the Pickering emulsions, the same preparation 159 
procedure as described above was adopted, but with the variant that the drug was 160 
previously dissolved in DMSO together with the CGPLAP (1:1 and 1:10 CG:PLA molar 161 
ratio derivatives were used at copolymer concentration of 0.5 mg/mL) and added to the 162 
aqueous phase. The amount of AmB associated into the Pickering emulsion was 163 
determined by the subsequent extraction of the drug with DMSO from the isolated 164 
formulations. The emulsion was dissolved in a fixed aliquot of DMSO and vortexed for 165 
emulsion destruction and complete extraction of the drug. Amphotericin B concentration 166 
was measured using a spectrophotometer UV-visible (Shimadzu UV 1800) at O=418 nm 167 
against a suitable calibration curve in DMSO. 168 
ABS = 0.04450 -0.00671 c                    (1) 169 
Where c is concentration in mg/mL. The AmB association efficiency was calculated from 170 
the following equation: 171 
 172 
 173 ܣݏݏ݋ܿ݅ܽݐ݅݋݊݂݂݁݅ܿ݅݁݊ܿݕሺ ? ሻ ൌ ൣܶ݋ݐ݈ܽܦݎݑ݃൧ െ ൣܨݎ݁݁ܦݎݑ݃൧ൣܶ݋ݐ݈ܽܦݎݑ݃൧ ൈ  ? ? ? 174 
 175 
To determine the state of aggregation of AmB in Pickering emulsion before AmB 176 
extraction,  Pickering emulsions with and without ( as a blank) drug were diluted in 177 
deionized water and the UV/VIS spectrum was ran. The experiment was also performed 178 
with a commercial Sigma AMB solution (with sodium deoxycholate).  179 
 180 
 181 
RESULTS AND DISCUSSION 182 
 183 
Physical characteristics of nanoprecipitated CGPLAP nanoparticles 184 
 185 
We hypothesized that the CG:PLA derivatives of low and high molar ratio would 186 
contribute to the formation and stabilization of Pickering o/w emulsions. To this end, we 187 
harnessed the self-assembly capacity of CGPLAP to form nanoparticles in an aqueous 188 
phase, along with that of spontaneous emulsification of an o/w emulsion by solvent 189 
displacement in the absence of added emulsifier. The expected structure of these 190 
Pickering emulsion systems is shown schematically in Figure 1.  191 
 192 
Central to gleaning understanding of the formation process of the Pickering emulsion 193 
systems was first to examine the particle size distribution of the CGPLAP pre-formed 194 
particles obtained by nanoprecipitation and self-assembly upon blending polymer DMSO 195 
solutions with water (the non-solvent). The size distribution profiles, both in intensity or 196 
volume  (%), of the nanoparticles obtained from the two derivatives of CGPLAP (1:1 and 197 
1:10) at the three tested concentrations are shown in Figure 2.  198 
 199 
Inspection of the size distribution profiles reveals that the particles formed by the 200 
CGPLAP derivative of lowest CG:PLA molar ratio (1:1) are strongly dependent on 201 
polymer concentration. The intensity (%) size distribution (Figure 2a) at c. 0.5 mg/mL 202 
shows a bimodal distribution with a predominant broad peak (centered at d. ~200 nm) 203 
and a smaller one (centered at d. ~6 nm). At 1.0 mg/mL though, these particle populations 204 
shift to d. ~550 and 50 nm, respectively. As the concentration increases to 2.0 mg/mL, 205 
only one population persists with an average diameter of ~550 nm. Similar trends are also 206 
reflected in the volume (%) distribution curves (Figure 2b), though as expected, the 207 
contribution of the smaller particles of the low and intermediate concentration is much 208 
more pronounced than in the intensity (%) profiles. In turn, the particles obtained by the 209 
CGPLAP of greater CG:PLA molar ratio (1:10), showed rather different concentration 210 
dependence in their intensity distribution profiles (Figure 2c). In this case, at the low and 211 
intermediate concentrations (0.5 and 1.0 mg/mL), three distinct populations were formed, 212 
each with average diameter values centered at ~8, ~80, and either ~800 (0.5 mg/mL) or 213 
~500 nm (1.0 mg/mL). At the highest concentration, only one predominant peak centered 214 
at d. ~300 nm was observed, though a minor population of smaller size (d. ~10-20 nm) 215 
was also appreciated. The corresponding volume (%) size distribution profiles for these 216 
particles (Figure 2d) showed only one single peak with average d. ~7-8 nm, with 217 
negligible dependence on polymer concentration. To account for the differences in the 218 
size distribution profiles of the two derivatives as a function of concentration, it is 219 
necessary to discuss the nanoprecipitation process, particularly in terms of the phase 220 
separation phenomena that can be at play. Previous studies have addressed the role of the 221 
phase equilibrium and polymer solution thermodynamics on the nanoprecipitation 222 
complex process [36]. The experimental evidence from such previous studies is consistent 223 
with the notion that there is a direct relationship between the behavior of Flory´s 224 
interaction parameter and the dimensions of the nanoparticles. In our own study, the 225 
precise value of the Flory-Huggins parameter (F) is unknown. Comparing the behavior 226 
of the two hydrophobic polysaccharide derivatives, CGPLAP 1:1 and 1:10, it appears that 227 
the concentration dependence is somewhat more pronounced for the less hydrophobic 228 
derivative. It can be expected that the polymer-solvent interactions be influenced by the 229 
degree of substitution and of polymerization of each derivative. Each of them would 230 
describe its own phase equilibrium diagram, and hence their dependence on concentration 231 
is expected to be different [37]. The more substituted hydrophobic derivative is likely to 232 
establish stronger interactions with DMSO, the organic solvent, than the less substituted 233 
one. At the same time, if only the volume (%) size distribution profiles are considered, it 234 
is clear that the smaller particles are obtained at the lowest polymer concentration, namely 235 
0.5 mg/mL for both derivatives. We examined the implications of the physical 236 
characteristics of the pre-formed particles on the formation and characteristics of the 237 
Pickering emulsions that comprised them, as discussed next.  238 
 239 
Characteristics of the Pickering emulsions before and after isolation 240 
 241 
The protocol to prepare Pickering emulsion systems consisted of two major steps, namely 242 
first preparing an aqueous phase comprised by CGPLAP nanoprecipitated particles, and 243 
by subsequent spontaneous emulsification upon blending the organic into the aqueous 244 
phase. The organic phase comprised Miglyol 812 (a biocompatible inert oil derived from 245 
coconut and palm), ethanol and acetone [31, 38]. Upon mixing the organic with the 246 
aqueous phase containing pre-formed nanoparticles of CGPLAP of the two CG:PLA 247 
molar ratio (1:1 and 1:10) at the varying concentrations, Pickering emulsion were 248 
spontaneously formed and stabilized by the adsorbed polysaccharide particles (Figure 1). 249 
The type of emulsion formed was oil-in-water type as confirmed by the droplet test after 250 
observing that the formulation dispersed immediately in water [33].  251 
The particle size distribution profiles of the furnished Pickering emulsions before and 252 
after their isolation are shown in Figure 3 for the two distinct derivatives of low (1:1) and 253 
high (1:10) CG:PLA molar ratio. Inspection of the profiles for the freshly prepared 254 
emulsions  (Figure 3a and 3b), reveals that the systems obtained from the nanoparticles 255 
made with CGPLAP (1:1) showed monomodal size distributions, when represented either 256 
in intensity or volume (%). Their Z-average diameter was ~450 nm and the distribution 257 
width spanned an order of magnitude (~100 to ~1000 nm). By contrast, the distribution 258 
curves for the freshly prepared systems obtained from CGPLAP (1:10), invariably 259 
exhibited two populations of particles, whose Z-average sizes were centered at d.~200 260 
and ~3500 nm, regardless of whether the results were expressed in intensity or volume 261 
(%). In general, slight differences were noticed between size distribution profiles of 262 
freshly prepared and isolated systems both in intensity or volume (%)  (Figure 3c and 3d, 263 
respectively). A moderate reduction in the overall size of the two systems is noticeable 264 
the consequence of isolation (see Figure 4 below). The monomodal and bimodal size 265 
distribution patterns observed, respectively, for the Pickering systems comprising 266 
CGPLAP (1:1) and CGPLAP (1:10) nanoparticles, persisted even after the isolation 267 
process though.  268 
The results of ]-potential, Z-average size, and polydispersity, for all the freshly prepared 269 
and isolated Pickering emulsions of monomodal size distributions of CGPLAP at 270 
different CGPLAP concentrations are summarized in Figure 4. Notice that the ]-potential 271 
values of freshly prepared systems (Figure 4a) decrease in a consistent trend from ] ~-44 272 
to ~-17 mV as the concentration of both CGPLAP (1:1) nanoparticles increases from 0.5 273 
to 2.0 mg/mL. A closer inspection of the data showed that, on the one hand, at the 274 
CGPLAP (1:1) concentrations of 0.5 and 1.0 mg/mL, the isolation process results in a 275 
low change in  ]-. At the highest concentration (2 mg/mL) of CGPLAP (1:1), isolation 276 
brought about an increase in ]-potential (from ~17 to ~-39 mV). In this latter case, the 277 
comparison between freshly prepared and isolated systems reveals that the magnitude of 278 
the relative increase in ]-potential of the emulsions is proportional to the increase in 279 
concentration of the particles. Notice also that only negligible differences in ]-potential 280 
are appreciable between isolated emulsions at the varying concentration of pre-formed 281 
nanoparticles of both CGPLAP derivatives.  282 
As regard the Z-average diameter, inspection of the data in Figure 4c, reveals that as the 283 
concentration of CGPLAP nanoparticles increases, the dimensions of the freshly prepared 284 
Pickering emulsions grow by approximately two-fold (from ~300to ~900 nm). After 285 
isolation though, notice that the corresponding Z-average diameters for the emulsions 286 
furnished from nanoparticles of CGPLAP of concentration 0.5 mg/mL, showed only a 287 
slight reduction with regard to the freshly prepared systems . These differences grew 288 
gradually larger in both type of systems as the concentration increased to 1.0 and 2.0 289 
mg/mL.  Notice also on top of the Z-average size panels in Figure 4c, that the PDI values 290 
after isolation is about half of freshly prepared Pickering emulsion and also for both 291 
system it increase with concentration.  292 
The physical characteristics of the Pickering emulsions formed by nanoparticles of the 293 
hydrophobic derivatives of cashew gum derivatives (Figure 3 and 4) described above 294 
seem to agree well with the notion that the pre-formed CGPLAP nanoparticles obtained 295 
by nanoprecipitation of the polysaccharide were amenable to stabilize oil-in-water 296 
Pickering emulsions upon adsorption of the small particles at the oil-water interface 297 
during the spontaneous emulsification process. Examination of the particle size 298 
distribution profiles of the Pickering emulsions (Figure 3) reveals that the more 299 
homogeneous (i.e., monomodal size distributions) systems were furnished by 300 
nanoparticles of CGPLAP (1:1) rather than by those comprising CGPLAP (1:10) 301 
nanoparticles (bimodal distributions). Hence, we can argue that the optimal Pickering 302 
emulsions can be obtained using the 1:1 CGPLAP derivative at 0.5 mg/mL after isolation, 303 
having a Z-average diameter of 241r5 nm, PDI ~0.12r0.01, ]-potential -40r5 mV. 304 
The interpretation to these results stems on the particle size profiles of the pre-formed 305 
nanoparticles (Figure 2). The presence of predominantly too small a fraction of 306 
nanoparticles (d.~10 nm) in CGPLAP (1:1) seems to be key for the effective formation 307 
of Pickering emulsions. In turn, the systems obtained from already less homogeneous (bi-308 
modal size distribution) pre-formed particles of CGPLAP (1:10), that seem to contain a 309 
fraction of large particles (d.~1000 nm), as expected, resulted in a non-monomodal 310 
particle size distributions. A plausible explanation to this bimodal distribution might be 311 
that at the two peaks correspond to a mixture between the Pickering emulsions and the 312 
unbound fraction of large CGPLAP (1:10) nanoparticles co-exist. However, the fact that 313 
after centrifugation the two populations still persisted, does not fully agree with this 314 
proposal. It is worth pointing out that the isolation of the emulsions upon centrifugation 315 
relies on the creaming separation of the droplets that remain at the surface, insofar as any 316 
matrix particles devoid of oil are bound to sediment at the bottom of the tube. Therefore, 317 
it seems unlikely that the population of large particle size corresponds to unbound 318 
CGPLAP (1:10) nanoparticles. If at all present, any surplus amount of large unbound 319 
particles would have settled down to the bottom of the tube upon centrifugation, and not 320 
remained in the close vicinity to the creamy layer of the emulsion. Therefore, we rather 321 
suggest the possibility of the existence two populations of Pickering emulsions of varying 322 
dimensions, namely one comprised by small and the other by large species; this 323 
suggestion seems more consistent with the experimental evidence. In the case of 324 
emulsions made from CGPLAP 1:1 nanoparticles, the size ratio of a polysaccharide 325 
particle-to-droplet is 0.011 (i.e., ~6 to ~550 nm), which is at the higher end of the typical 326 
size ratio of Pickering stabilized emulsions (i.e., 0.001 to 0.01) [39]. In the case of 327 
emulsions furnished by nanoparticles of CGPLAP 1:1 with larger Z-average size obtained 328 
at concentrations of 1.0 and 2.0 mg/mL, Pickering droplets of larger size were also formed 329 
(Figure 4). 330 
The more detailed comparison of the characteristics of the Pickering emulsions furnished 331 
from CGPLAP nanoparticles at the different concentrations allowed to gain further 332 
insight into the mechanisms at play. As illustrated in Figure 4a, the behavior of the ]-333 
potential of the different Pickering emulsions of freshly prepared systems decreased 334 
consistently with increasing concentration of the CGPLAP particles. It was extremely 335 
revealing to realize that the ]-potential values attained by the freshly prepared emulsions 336 
of greater CGPLAP concentration matched closely those of the self-assembled 337 
nanoparticles (~-20 mV). This result is fully consistent with the idea that as the surface 338 
of the emulsions tends to be fully covered by CGPLAP nanoparticles, the ]-potential of 339 
the emulsions should match that of the nanoparticles. Without further data for 340 
formulations at yet greater concentrations beyond 2 mg/mL, it is difficult to judge at this 341 
stage whether the surface of the emulsions became fully saturated with CGPLAP 342 
nanoparticles at such concentration. 343 
Upon isolation, however, the physical characteristics of the Pickering emulsions changed 344 
dramatically as described above (Figure 4a). A plausible general explanation to account 345 
for the observed increase in ]-potential after isolation, is that centrifugation causes 346 
desorption of the CGPLAP nanoparticles from the interface of the emulsions. Consistent 347 
with this view is the fact that at the greatest concentration (2 mg/mL), the magnitude of 348 
the difference (increase) is greatest. The apparent slight increase in ]-potential of the 349 
Pickering droplets upon isolationcan be explained as the expected consequence of a less 350 
effective coverage of the emulsion surface. Miglyol 812® oil is known to be a mixture of 351 
triglycerides of caprilic and caproic acids derived from coconut and palm kernel. Even 352 
when the fatty acids in Miglyol occur predominantly as esterified as triglycerides, there 353 
is a small fraction of nonesterified fatty acids that confer the oil a slight acidity. The 354 
carboxylate groups of this small fraction of free fatty acids are bound to be fully exposed 355 
to the water phase, hence the highly negative ]-potential of oil droplets. Therefore, the 356 
decrease in ]-potential of the Pickering emulsions with increasing CGPLAP 357 
concentration, is consistent with the increase in the effective uncoated area of the oil 358 
droplets.   359 
The available biophysical evidence presented above is consistent with the adsorption of 360 
the preformed CGPLAP nanoparticles to the interface of the o/w emulsion formed by 361 
solvent displacement. However, whether CGLAP nanoparticles disassemble upon 362 
adsorbing at the o/w interface and contribute to stabilize the emulsion due to the 363 
amphiphilic character of CGLAP, cannot be ruled out. Contact angle or FRET 364 
fluorescence measurements to probe the integrity of the nanoparticles during the 365 
emulsification process would have shed further light into this issue, and are yet to be 366 
considered in future studies.   367 
Detachment of nanoparticles of CGPLAP from the interface upon centrifugation is also 368 
fully consistent with the observed overall decrease in Z-average size (Figure 4c). We 369 
reasoned that if the Pickering emulsions were conceived to be structured as schematically 370 
shown in Figure 1, it would be expected that their dimensions be influenced by the corona 371 
of putatively adsorbed nanoparticles. Hence, detachment of these nanoparticles from the 372 
interface driven by the centrifuge force would be expected to result in a noticeable 373 
decrease in size. A rough analysis of the size data shows that at the highest concentration 374 
of 2.0 mg/mL, the Z-average size decreases from ~900 to ~500 nm. The magnitude of 375 
this difference (~400 nm) is many-fold larger than the Z-average diameter of the 376 
nanoparticles thought to be adsorbed at the interface (~6 nm). Given this large difference, 377 
it might be that not a single but several layers of nanoparticles are adsorbed so as to 378 
account for such too thick an interface.   379 
The free energy required for desorption of particles is known to be given by the following 380 
equation [40]: 381 
 382 
            (2) 383 
 384 
where, Jis the oil-water surface tension, r is the radius of the particle, and T is the contact 385 
angle between the liquid and a solid substrate comprising of the same material as that for 386 
the particle. In general, this energy is much greater than the sole thermal energy (kBT), 387 
even for small particles. Hence, particles once adsorbed at the interface, are very difficult 388 
to displace. This is the reason behind the high efficacy of nanoparticles as stabilizers of 389 
colloids such as emulsions and foams.  390 
Even when the adsorption of particles at Pickering interfaces is often irreversible, the 391 
application of external fields, has been shown to allow detachment of magnetic or 392 
electrically polarizable particles [41]; [42].  Also, it has been argued that a higher density 393 
of particles relative to the surrounding medium may be enough to detach particles from 394 
bubbles [43]. In our work, we suggest that the centrifuge force causes the emulsion 395 
droplets to rise while the particles are pulled down by the gravitational force, under a 396 
similar process as the cited example for Pickering stabilized bubbles. The fact that the 397 
differences in Z-average size and ]-potential are magnified as the concentration of 398 
E = g p r
2 1 - cos q( )2
CGPLAP nanoparticles increases, is consistent with the latter view in that a higher density 399 
of particles relative to the surrounding medium, favors their detachment from the 400 
interface.  401 
 402 
Stability of Pickering emulsions in storage conditions  403 
 404 
The stability of the isolated Pickering emulsions CGPALP 1:1  during their storage at 4Û& 405 
was assessed from the evolution of the Z-average size (Figure 5). Notice in Figure 5 that 406 
for the emulsions formed with CGPLAP 1:1 nanoparticles at the three explored 407 
concentrations, the Z-average size of the emulsions remained constant for up to 28 days. 408 
The trend in Z-average size at the three concentrations is similar to that observed in water 409 
for freshly prepared and isolated particles (Figure 4). Overall, the formulations appear to 410 
be stable during storage at refrigeration temperature. This is a result of practical 411 
significance, as it anticipates that the formulations could be stored for almost one month 412 
under refrigeration.  413 
 414 
Amphotericine B (AmB) encapsulation and loading efficicency 415 
 416 
The other important aspect to evaluate for the CGPLAP nanoparticles-stabilized 417 
Pickering emulsions was their capacity to associate AmB, which  is a drug of low water 418 
solubility. Therefore, to load AmB into the formulations (aAlthough the bimodal size 419 
distribution observed for CGPLAP 1:10 it was also tested to encapsulate AmB), we chose 420 
the condition of CGPLAP nanoparticles at 0.5 mg/mL and the drug was loaded in the 421 
aqueous phase dissolved in DMSO. As shown above, this concentration of CGPLAP 422 
afforded optimal physical characteristics for the formation of Pickering emulsions.  423 
The appreciable change in color from a milky white to a yellowish emulsion upon pouring 424 
the organic into the aqueous phase, along with the absence of formation of a precipitate, 425 
gave a first hint that AmB incorporated into the formulations successfully.  426 
 427 
 428 
 429 
 430 
 431 
 432 
 433 
In aqueous media and at low concentrations (5.0×10-7 M aqueous solution), the UV/VIS 434 
spectrum of AmB showed four absorbance bands in the O range from 320 to 450 nm. 435 
Three distinct major absorption bands are centered at O ~375, ~395, and ~418 nm, and a 436 
flat small shoulder at O~357 nm[28]; [44].  437 
In general, the spectral changes induced by the aggregation of AmB may be represented 438 
as the value of the ratio of the intensities of the major absorption bands at O=380 and 409 439 
nm (i.e., ~ A350/~A409 ratioThis ratio assumes a value of ~ 2.0 for AmB aggregated 440 
species, and of ~0.25 for the monomeric form [45-46].  In commercial formulations of 441 
AmB (e.g., Ambizone® and Fungizone®) A350/A409 ratios of 2.9 and 4.8 have been 442 
determined, respectively [47], thus reflecting that AmB occurs in the aggregated form in 443 
such both cases.   444 
Table 1 summarizes the data corresponding to the association of AmB into the Pickering 445 
emulsions obtained from the two different nanoparticles of CGPLAP 1:1 and 1:10. 446 
Comparison of the drug association efficiency for both type of formulations, reveals that 447 
the entrapment of AmB increases with the loading, particularly for the systems 448 
comprising nanoparticles of CGPLAP 1:10 that increase the association efficiency of 449 
AmB by nine-fold upon doubling the amount of loaded drug. By contrast, the magnitude 450 
of the increment of associated AmB due to the increase in AmB initial mass for the 451 
systems comprising nanoparticles of CGPLAP 1:1 was moderate (only ~20%), though 452 
the AmB association efficiency of the formulations with 5 mg of AmB was more than 453 
three-fold greater than that of the systems comprising nanoparticles of CGPLAP 1:10 at 454 
equivalent loading. 455 
To make sense of the drug association results of AmB-loaded Pickering emulsions, it is 456 
worth to discuss in closer detail the protocol used to formulate these systems. Due to the 457 
restrictions imposed by the low solubility of AmB neither in ethanol or acetone, it was 458 
not possible to load it into the oil core of the nanoemulsions, as it would have been the 459 
ideal case. Hence, AmB had to be dissolved in the DMSO solution needed to dissolve 460 
CGPLAP. Upon mixing such solution in water, this led to the formation of 461 
nanoprecipitated polysaccharide particles. These particles were subsequently used to 462 
stabilize the Pickering emulsion droplets upon mixing the aqueous into the organic phase 463 
as already discussed above. Upon precipitation of CGPLAP particles driven by the phase 464 
equilibrium of the CGPLAP solvent (DMSO) and non-solvent (water), it would be 465 
expected that AmB associates preferentially with the hydrophobic core of the CGPLAP 466 
nanoparticles, while contributing to reinforce hydrophobic associations. This would be 467 
consistent with the abrupt increase in association efficiency for the systems comprising 468 
CGPLAP 1:10 nanoparticles observed upon increase in drug loading, when compared to 469 
those comprising nanoparticles of CGPLAP 1:1. We venture to suggest that under this 470 
scenario, AmB would remain associated to the nanoparticles sitting at the oil-water 471 
interface of the stabilized Pickering emulsions. Yet an alternative possibility would be 472 
that upon creation of the emulsions, unassociated AmB remaining in the aqueous phase, 473 
may prefer to migrate to the oily core of the emulsions, under a similar mechanism that 474 
drives the spontaneous formation of the emulsion droplets (i.e., solvent displacement). 475 
Upon mixing the organic into the aqueous phase, acetone and ethanol instantaneously 476 
move to the aqueous phase, leaving depleted the oil droplets phase. However, free AmB 477 
in the aqueous phase might also get trapped into the newly formed oil droplets.  478 
Yet another important aspect of notice was that upon centrifugation the Pickering 479 
emulsions to isolate them, a yellow colored pellet was observed at the bottom of the vials 480 
(See Figure S1 Supporting Information). This could be diagnostic of the presence of either 481 
precipitated AmB or unbound CGPLAP nanoparticles. Therefore, it stands to reason that 482 
AmB partitions itself between the emulsion droplets (either in the CGPLAP nanoparticles 483 
or at the core), a free fraction in the subnatant and the insoluble pellet that settles down 484 
upon centrifugation. At present, we have no experimental evidence to elucidate further 485 
the mechanisms at play nor to probe the preferred localization and molecular organization 486 
of AmB in the Pickering emulsions (i.e., whether it occurs in the oil core or at the adsorbed 487 
CGPLAP nanoparticles), but this can be the focus of future studies (e.g., using a 488 
fluorescent tagged AmB, as in previous studies) [48]. 489 
The UV-vis spectrum for 1: 1 and 1:10 GCPLAP AmB loaded emulsions and for a 490 
solution of commercial Sigma AmB in waterare shown in Figure 6. The spectrum shows 491 
a broad band at maximum intensity in 336 nm and 340 nm for derivatives 1: 1 and 1:10, 492 
respectively. Spectra with similar absorption profiles are found in chitosan and dextran 493 
sulfated  nanoparticles [49] and in lipid complexes composed of DMPC and DMAC [50]. 494 
For CGPLAP emulsions 1: 1 and 1:10 a small displacement between bands (I) and (IV) 495 
was observed (340 and 342 nm lengths for the band (I) and 407 and 406 nm for the band 496 
(IV), for the 1: 1 and 1:10 derivatives, respectively). The I/IV ratio for CGPLAP 1: 1 and 497 
CGPLAP 1:10 was 1.7 and 1.6 respectively while for a commercial AmB solution the 498 
ratio was 2.5, indicating that the AmB is not fully aggregated within the emulsion 499 
formulation. For the sulfated chitosan and dextran nanoparticles, the I/IV ratio found was 500 
3.6 [49].  Commercial formulations such as Amphocil®, Fungizone®, Abelcet® and 501 
Ambisone® were found in the aggregate form (at 5% dextrose) with I/IV ratios of 9.1, 502 
4.8, 1.3 and 2.9, respectively [47,51]. So, when compared with commercial formulations 503 
it seems that the Pickering formulations protect AmB against more extensive aggregation. 504 
This is a remarkable result particularly due to the importance of the aggragate form on 505 
the increase of toxicity. 506 
 507 
 508 
 509 
 510 
CONCLUSION 511 
 512 
In summary, in this work, we give proof-of-concept of the feasibility to prepare a 513 
Pickering emulsion system based on a hydrophobic derivative of cashew gum 514 
polysaccharide. To this end, nanoprecipitated polysaccharide particles were subsequently 515 
adsorbed at the interface of oil in water emulsions obtained by solvent displacement. As 516 
expected, the characteristics of the nanoparticles influence those of the Pickering 517 
emulsions. The route of preparing these systems offers the possibility to associate 518 
amphotericin B into these systems and associate it with efficiencies up to ~47% and 519 
presumably in less aggregated form than commercial formulations. Subsequent studies 520 
will examine the in vitro release and toxicity of these novel formulations.   521 
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FIGURES AND TABLES 728 
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Scheme 1. Structure of AmB 738 
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 749 
Figure 1. Schematic illustration of the Pickering emulsion stabilized by CGPLAP self-750 
assembled nanoparticles. The red core of the CGPLAP nanoparticles, represents the 751 
hydrophobic regions, while the black lines, do the hydrophilic polysaccharide. 752 
 753 
 754 
 755 
Figure 2. Size distribution profile of NP´s (a) CGPLAP 1:1 in intensity, (b) CGPLAP 1:1 756 
in volume, (c) CGPLAP 1:10 in intensity and (d) CGPLAP 1:10 in volume (size and 757 
standard deviation by intensity and volume (%) are depicted in Table A at supplementary 758 
information). 759 
 760 
 761 
Figure 3. Size distribution profile of Pickering emulsions stabilized by CGPLAP 762 
nanoparticles (0.5 mg/mL). Freshly prepared:  (a) in intensity and (b) in volume; and 763 
Isolated: (c) in intensity and (d) in volume(size and standard deviation by intensity and 764 
volume (%) are depicted in Table B at supplementary information) 765 
 766 
 767 
  768 
Figure 4. ȗ- potential for (a) Fresh, (b) Isolated, Z-average size and Polydispersity for (c) 769 
fresh and (d) isolated Pickering Emulsion (mean average values ± SD; different letters in 770 
bars denote significant differences among treatments p  after unpaired t-tests; n = 771 
3).  772 
 773 
Figure 5 . Stability of the isolated Pickering emulsion during storage at 4 °C. Systems 774 
comprising CGPLAP 1:1 (please add X lable) 775 
 776 
 777 
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 780 
 781 
Figure 6. UV/VIS spectrum of AmB encapsulated in  Pickering emulsion of CGPLAP 782 
1:1 and CGPLAP 1:10 encapsulated and of commercial Sigma AmB solution 783 
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Table 1. Association of amphotericin B-loaded in Pickering emulsions 797 
obtained from CGPLAP derivatives nanoparticles (0.5 mg/mL). 798 
Formulation Initial AmB 
(mg) 
A.E.1      
(%)
 
CGPLAP 1:1 
10 27.4±19 
5 21.1±7.9 
CGPLAP 1:10 
10 47.8±9.7 
5 5.7±5.6 
1A.E.=Drug association efficiency 799 
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